LBA 01 - Late-breaking Abstract Session

Presentations

• 02:15pm - 02:25pm ET

  TRIDENT: Phase 3 Trial of Tumor Treating Fields (TTFields) Therapy Concurrent with Temozolomide (TMZ) Radiochemotherapy Followed by Maintenance TMZ and TTFields for Newly Diagnosed Glioblastoma (ndGBM)

  Speaker: Wenyin Shi, MD, PhD - Thomas Jefferson University, Philadelphia
• 02:25pm - 02:35pm ET

  Chemoradiotherapy (CRT) Followed By Consolidation Durvalumab (D) In Patients (pts) with Resectable or Borderline Resectable Stage IIB-IIIB NSCLC Who Become Unresectable during Neoadjuvant Treatment (Tx): Results from the Phase 2 MDT-Bridge Study

  Speaker: Andrea Filippi, MD - Fondazione IRCCS - Istituto Nazionale dei Tumori, Milan
• 02:35pm - 02:45pm ET

  NRG-HN009 Randomized Phase II/III Trial of RT + Cisplatin Q3 Weeks vs RT + Cisplatin Weekly for Patients with Locoregionally Advanced SCCHN: p16-Negative Phase II Toxicity Results

  Speaker: Paul Harari, MD, FASTRO - University of Wisconsin School of Medicine and Public Health, Madison
• 02:45pm - 02:55pm ET

  A Phase II Trial of Induction Paclitaxel Followed by Concurrent Paclitaxel and Radiation Therapy for Cutaneous Angiosarcoma

  Speaker: Silpa Raju-Salicki, MD - Washington University in St. Louis, St. Louis
• 02:55pm - 03:05pm ET

  A Randomized, Phase II Clinical Trial of Stereotactic Body Radiation Therapy Or Conventionally Fractionated Concurrent Chemotherapy and Radiation Therapy Preoperatively for Pancreatic Adenocarcinoma, the SOFT Preop Study

  Speaker: William Hall, MD - Medical College of Wisconsin, Milwaukee
• 03:05pm - 03:15pm ET

  Neoadjuvant Radiotherapy in Breast Cancer: A Study on the Optimal Sequencing of Radiation in Breast Cancer (NeoORB)

  Speaker: Rishi Nair, MBBS - All India Institute of Medical Sciences, Jodhpur, Jodhpur
• 03:15pm - 03:25pm ET

  Long term outcomes of sexual function in the PACE-A trial: A multicentre randomised study of radical prostatectomy vs stereotactic body radiotherapy (SBRT) for early localised prostate cancer

  Speaker: Nicholas van As, MD, MB - The Royal Marsden NHS Foundation Trust, London